跳至主要内容
临床试验/JPRN-UMIN000026826
JPRN-UMIN000026826已完成未知

Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer. - PRiDICT study

Clinical Research Center, Saga University Hospital0 个研究点目标入组 240 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients have history of VTE in the past. 2. Patients have recently received radiotherapy except for palliative radiation therapy, chemotherapy and surgery except for minor surgery within the last 4 weeks. 3. Patients using anticoagulant drugs (warfarin, heparin and Direct oral anticoagulants) consistently. 4. Patients have serious renal disease: creatinine clearance<30ml/min, or hypersensitivity to CT contrast media. 5. Patients with active infections. 6. Pregnant or possibly pregnant women. 7. Patients with lower limb amputation. 8. Patients who are inappropriate as a subject of the study judged by the treating physicians or investigator.

研究者

发起方
Clinical Research Center, Saga University Hospital

相似试验

Prospective study for predictive biomarkers and... | 临床试验